Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 5.60
-0.05 (-0.88%)
At close: Jan 30, 2026
Genfit Market Cap
Genfit has a market cap or net worth of €278.85 million as of January 30, 2026. Its market cap has increased by 63.99% in one year.
Market Cap
278.85M
Enterprise Value
310.26M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.60
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 278.85M, an increase of 90.91%. That is a compound annual growth rate of 3.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 278.85M | 6.36% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 869.05M |
| MedinCell | 764.01M |
| Valneva SE | 674.24M |
| Transgene | 251.37M |
| Cellectis | 236.14M |
| Innate Pharma | 145.05M |
| ABIONYX Pharma | 134.06M |
| Adocia | 125.40M |